Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
Lab Test

Myeloma Cytogenetics: Karyotyping and FISH Analysis for del17p, IGH Breakapart, del13q, t(4;14), and t(14;16)

  • Home
  • Hyderabad
  • Lab Test
  • Myeloma Cytogenetics: Karyotyping and FISH Analysis for del17p, IGH Breakapart, del13q, t(4;14), and t(14;16)
What is the significance of del17p in multiple myeloma?

Deletion of the short arm of chromosome 17 (del17p) is associated with a high-risk form of multiple myeloma. It is often associated with resistance to standard treatments and a poor prognosis.

What is IGH breakapart, and why is it important?

IGH breakapart refers to rearrangements involving the immunoglobulin heavy chain gene (IGH) on chromosome 14. These rearrangements can play a significant role in the development of multiple myeloma and can affect the patient’s response to treatment.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

Translocation t(4;14) involves an exchange of genetic material between chromosomes 4 and 14. This abnormality is associated with a more aggressive form of multiple myeloma and may necessitate specific targeted therapies.

Translocation t(14;16) is another chromosomal abnormality in which parts of chromosomes 14 and 16 are exchanged. Like t(4;14), this translocation is associated with a high-risk form of multiple myeloma.

A bone marrow aspiration procedure is used to collect the sample. This involves inserting a needle into the bone (usually the hip bone) to extract a small amount of bone marrow.

No special preparation is required for Myeloma Cytogenetics testing. However, it’s important to inform your doctor of any medications or supplements you are taking.

The results can influence the course of treatment. Certain chromosomal abnormalities may indicate that more aggressive treatment is needed, while others may suggest a good response to standard therapies.

Myeloma Cytogenetics is usually performed at the time of diagnosis to help establish a treatment plan. Your doctor may recommend repeating the test if there is a change in your condition or to monitor the response to treatment.

As with any procedure involving a needle, there is a small risk of infection, bleeding, or bruising at the site where the needle was inserted.

While lifestyle changes cannot cure multiple myeloma, maintaining a healthy lifestyle can help improve overall health and may positively influence how well you respond to treatment.

Treatment options for multiple myeloma include chemotherapy, targeted therapy, immunotherapy, stem cell transplant, and supportive care to manage symptoms.

It’s important to consult a hematologist or oncologist who specializes in the treatment of blood cancers, including multiple myeloma.

As of now, multiple myeloma is not considered curable, but it is treatable. Advances in treatment have significantly improved the quality of life and survival rates for multiple myeloma patients.

Multiple myeloma is a complex disease with a variety of genetic abnormalities. Myeloma Cytogenetics, involving Karyotyping and FISH analysis, is crucial in understanding the genetic basis of the disease. This testing plays a critical role in diagnosis, risk stratification, and guiding therapy. If you or a loved one has been diagnosed with multiple myeloma, it’s essential to understand the value of cytogenetic testing and work closely with your doctor to develop a personalized treatment plan.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet